-
Is 3-D Mammography Better?A study enrolling patients compares a newer form of digital mammography to conventional 2-D digital mammography.
by Marci A. Landsmann
-
When Cancer Survivors Get Another CancerPatients diagnosed with a second cancer may be unnecessarily excluded from clinical trials.
by Kate Yandell
-
Chemotherapy EssentialsStock your bag with these useful items before your next infusion session.
by Jamie L. Schwachter
-
Welcome to Our New WebsiteAn updated site and a new digital editor means better and faster cancer coverage for our readers.
by Cancer Today Staff
-
Study Shows Minority Participation in Clinical Trials May Be DecliningResearcher speculates that costly genetic testing may be limiting outreach to underserved communities.
by Marci A. Landsmann
-
A Focus on Pediatric Cancer ScreeningThe AACR shares research papers that summarize recommendations for monitoring children and adolescents with cancer predisposition syndromes.
by Garrett M. Brodeur
-
Revised Prostate Cancer Screening Guidelines Proposed
The U.S. Preventive Services Task Force suggests an individualized approach to prostate cancer screening.
-
The Patient PerspectiveIn a sea of p-values and distribution curves, patient advocates and survivors at a scientific gathering remind researchers who is behind the numbers.
by Marci A. Landsmann
-
Immunotherapy CombinationsResearchers are combining immunotherapies with each other and with other treatments in hopes that a larger proportion of patients will have long-term benefits.
by Kate Yandell
-
Patient Advocates Go to WashingtonPatient advocates meet amid an outcry about research funding cuts, participate in a meeting with FDA officials and visit Capitol Hill.
by Marci A. Landsmann
Legislation to speed cancer drug development for children and adolescents requires drug companies to test drugs in children, but trials in people under 18 may take years to generate results.
by Marci A. Landsmann
Understanding Stress and CancerA symposium at the AACR Annual Meeting explores how social factors contribute to elevated risk of cancer in some populations.
by Eric Fitzsimmons
Exploring Amino Acids’ Impact on Tumor GrowthResearchers are investigating how to match specific dietary changes with therapy to impede cancer progression.
by Thomas Celona
Study Shows Minority Participation in Clinical Trials May Be DecliningResearcher speculates that costly genetic testing may be limiting outreach to underserved communities.
by Marci A. Landsmann
-
Using Lymphocytes to Attack TumorsSooner rather than later may be the best strategy for using an experimental treatment for advanced melanoma.
-
Closing Disparities Through Genetic TestingOlufunmilayo Olopade seeks widespread use of testing to encourage prevention and early detection of deadly cancers.
Learning Medicare’s ABCDs
